Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

746
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
746
Cancer Therapies02:49

Cancer Therapies

8.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K
Cancer Therapies02:49

Cancer Therapies

2.4K
2.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
1.1K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

455
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
455

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glycolytic Stimulation Is Not a Requirement for M2 Macrophage Differentiation.

Cell metabolism·2018
Same author

Hypercholesterolemia after conversion to sirolimus as primary immunosuppression and cardiac allograft vasculopathy in heart transplant recipients.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2018
Same author

Ubiquitous yet unseen: microvascular endothelial dysfunction beyond the heart.

European heart journal·2018
Same author

Cardiorenal biomarkers: one step closer.

Journal of laboratory and precision medicine·2018
Same author

Microvascular obstruction in non-infarct related coronary arteries is an independent predictor of major adverse cardiovascular events in patients with ST segment-elevation myocardial infarction.

International journal of cardiology·2018
Same author

Coronary endothelial function and spontaneous coronary artery dissection.

European heart journal. Acute cardiovascular care·2018

Related Experiment Video

Updated: Apr 25, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

10.8K

An update on cardio-oncology.

Joerg Herrmann1, Amir Lerman1

  • 1Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.

Trends in Cardiovascular Medicine
|August 26, 2014
PubMed
Summary

Cardio-oncology addresses cancer treatment's cardiovascular side effects. This evolving field optimizes care for cancer patients with heart conditions, improving survival outcomes.

Area of Science:

  • Oncology
  • Cardiology
  • Cardio-Oncology

Background:

  • Cancer survival rates have improved, leading to extended treatment for older patients and those with comorbidities.
  • Cancer therapies, including new tyrosine kinase inhibitors, can cause significant cardiovascular morbidity and mortality.
  • Cardiovascular diseases are a critical concern for cancer patients, both pre-existing and treatment-induced.

Purpose of the Study:

  • To review recent advancements in cardio-oncology.
  • To highlight the management of cardiotoxicities, vascular toxicities, and arrhythmias in cancer patients.
  • To emphasize the collaborative efforts shaping the field of cardio-oncology.

Main Methods:

  • Literature review of recent developments in cardio-oncology.

More Related Videos

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.5K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K

Related Experiment Videos

Last Updated: Apr 25, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

10.8K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.5K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K
  • Analysis of cardiotoxicities, vascular toxicities, and arrhythmias associated with cancer treatments.
  • Examination of the collaborative efforts and consensus statements in the field.

    • Main Results:

    • Cardio-oncology has emerged as a critical discipline for managing cardiovascular complications in cancer patients.
    • New cancer drugs present unique and severe cardiovascular side effects.
    • Multidisciplinary collaboration is essential for optimal patient care.

    Conclusions:

    • Cardio-oncology is rapidly evolving, integrating cardiology and oncology expertise.
    • Effective management strategies are being developed for cancer-related cardiovascular diseases.
    • Collaborative programs and consensus statements are crucial for advancing patient care and outcomes.